aTyr Pharma Announces Workforce Reduction Of About 60% To Focus On Efzofitimod Program; Expects $13M Reduction In Annualized Operating Expenses Beginning Q4 2026

Loading news article.

aTyr Pharma Announces Workforce Reduction Of About 60% To Focus On Efzofitimod Program; Expects $13M Reduction In Annualized Operating Expenses Beginning Q4 2026 | WAPE

aTyr Pharma Announces Workforce Reduction Of About 60% To Focus On Efzofitimod Program; Expects $13M Reduction In Annualized Operating Expenses Beginning Q4 2026

Article summary

Related companies

Comments —